Pharmacological management of the psychiatric aspects of traumatic brain injury
暂无分享,去创建一个
[1] J. Collie. Malingering in Accident and Disease , 1913 .
[2] B. Pitt. Psychopharmacology , 1968, Mental Health.
[3] W. Lishman,et al. Brain Damage in Relation to Psychiatric Disability After Head Injury , 1968, British Journal of Psychiatry.
[4] G. Edwards. Textbook of psychopharmacology , 1975, Nature.
[5] C. Vecht,et al. Homovanillic Acid and 5-Hydroxyindoleacetic Acid Cerebrospinal Fluid Levels: A Study With and Without Probenecid Administration of Their Relationship to the State of Consciousness After Head Injury , 1975 .
[6] L. Judd,et al. Schizophrenia-like illness following head injury. , 1981, Psychosomatics.
[7] D. M. Feeney,et al. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. , 1982, Science.
[8] Godfrey D. Pearlson,et al. POST-STROKE DEPRESSION : A DOUBLE-BLIND STUDY , 2003 .
[9] A. V. Zomeren,et al. Residual complaints of patients two years after severe head injury. , 1985 .
[10] Saran As. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants. , 1985 .
[11] D. Woolston,et al. Agitation in closed head injury: haloperidol effects on rehabilitation outcome. , 1985, Archives of physical medicine and rehabilitation.
[12] A. Saran. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants. , 1985, The Journal of clinical psychiatry.
[13] J. Coyle,et al. Effective management with lithium of a persistent, post-traumatic hypomania in a 10-year-old child. , 1985, Journal of developmental and behavioral pediatrics : JDBP.
[14] A. V. Zomeren,et al. Residual complaints of patients two years after severe head injury. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[15] J. Gerring. Psychiatric sequelae of severe closed head injury. , 1986, Pediatrics in review.
[16] D. Patterson,et al. Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. , 1987, The Journal of nervous and mental disease.
[17] M. Trimble. Anticonvulsant Drugs and Cognitive Function: A Review of the Literature , 1987, Epilepsia.
[18] D. Parmelee,et al. Carbamazepine-lithium toxicity in brain-damaged adolescents. , 1988, Brain injury.
[19] S. Nizamie,et al. Mania following head injury: Case reports and neuropsychological findings , 1988, Acta psychiatrica Scandinavica.
[20] Stewart Jt,et al. Bipolar illness following traumatic brain injury: treatment with lithium and carbamazepine. , 1988 .
[21] P. Keck,et al. Head injury, bipolar disorder, and response to valproate. , 1988, Comprehensive psychiatry.
[22] J. Whyte,et al. Lithium Carbonate for Aggressive Behavior or Affective Instability in Ten Brain-injured Patients , 1989, American journal of physical medicine & rehabilitation.
[23] J. Whyte,et al. The Incidence of Seizures during Tricyclic Antidepressant Drug Treatment in a Brain-Injured Population , 1990, Journal of clinical psychopharmacology.
[24] J. Corrigan,et al. The structure of head-injured patients' neurobehavioural complaints: a preliminary study. , 1990, Brain injury.
[25] C. Gualtieri. Buspirone: Neuropsychiatric effects , 1991 .
[26] R. Marin,et al. Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[27] C. Gualtieri,et al. Neuropsychiatry and Behavioral Pharmacology , 1990, Springer New York.
[28] S. Arndt,et al. Depression in patients with acute traumatic brain injury. , 1992, The American journal of psychiatry.
[29] M. Mobayed,et al. Treatment resistance of depression after head injury: a preliminary study of amitriptyline response , 1992, Acta psychiatrica Scandinavica.
[30] Depression in patients with acute traumatic brain injury. , 1992 .
[31] B. Pentland,et al. Fluoxetine as a treatment for emotional lability after brain injury. , 1992, Brain injury.
[32] G. Seliger,et al. Fluoxetine improves emotional incontinence. , 1992, Brain injury.
[33] J. Lewin,et al. Successful Treatment of Episodic Dyscontrol with Carbamazepine , 1992, British Journal of Psychiatry.
[34] T. McAllister,et al. Neuropsychiatric sequelae of head injuries. , 1992, The Psychiatric clinics of North America.
[35] M. Boyeson,et al. EFFECTS OF TRAZODONE AND DESIPRAMINE ON MOTOR RECOVERY IN BRAIN-INJURED RATS1 , 1993, American journal of physical medicine & rehabilitation.
[36] B. Dobkin,et al. Dopamine agonist treatment of antegrade amnesia from a mediobasal forebrain injury , 1993, Annals of neurology.
[37] S. Arndt,et al. Are There Symptoms that Are Specific for Depressed Mood in Patients with Traumatic Brain Injury? , 1993, The Journal of nervous and mental disease.
[38] S. Arndt,et al. Secondary mania following traumatic brain injury. , 1993, The American journal of psychiatry.
[39] B. Beermann. Side effects of long acting cholinesterase inhibitors , 1993, Acta neurologica Scandinavica. Supplementum.
[40] B. Wroblewski,et al. Paradoxical akathisia caused by clonazepam, clorazepate and lorazepam in patients with traumatic encephalopathy and seizure disorders: a subtype of benzodiazepine-induced disinhibition? , 1993, Behavioural neurology.
[41] J. Kornhuber,et al. Amantadine withdrawal and neuroleptic malignant syndrome , 1993, Neurology.
[42] J. Bleiberg,et al. Effects of dexedrine on performance consistency following brain injury: a double-blind placebo crossover case study , 1993 .
[43] M. Crismon,et al. Clozapine response and adverse effects in nine brain-injured patients. , 1993, Journal of clinical psychopharmacology.
[44] P. Baruch,et al. Efficacy of the combination of buspirone and carbamazepine in early posttraumatic delirium. , 1994, The American journal of psychiatry.
[45] M. Dombovy,et al. Clinical use of amantadine in brain injury rehabilitation. , 1994, Brain injury.
[46] P. Watkins,et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. , 1994, JAMA.
[47] S. Garner,et al. N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. , 1995, Brain injury.
[48] P. Baruch,et al. Neuroleptic Associated Tardive Dyskinesias in Young People with Psychoses , 1995, British Journal of Psychiatry.
[49] X. Chai,et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. , 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica.
[50] B. Wroblewski,et al. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study. , 1996, The Journal of clinical psychiatry.
[51] T. Guilmette,et al. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. , 1996, Archives of physical medicine and rehabilitation.
[52] R. Zafonte,et al. Sleep disturbance in traumatic brain injury: pharmacologic options. , 1996, NeuroRehabilitation.
[53] D. DeMaso,et al. Use of risperidone in psychotic disorder following ischemic brain damage. , 1996, Journal of child and adolescent psychopharmacology.
[54] L. Fugate,et al. Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. , 1997, Archives of physical medicine and rehabilitation.
[55] D. Efron,et al. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. , 1997, Pediatrics.
[56] D. Clinchot,et al. Medications To Enhance Cognitive Functioning , 1997 .
[57] H. Coslett,et al. Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. , 1997, American journal of physical medicine & rehabilitation.
[58] B. Wilson,et al. Cognitive Rehabilitation: How it is and how it might be , 1997, Journal of the International Neuropsychological Society.
[59] M. Bryk,et al. My mother caused my illness: the story of a survivor of Münchausen by proxy syndrome. , 1997, Pediatrics.
[60] M. Childers,et al. Psychomotor agitation following gabapentin use in brain injury. , 1997, Brain injury.
[61] S. W. Stanislav. Cognitive effects of antipsychotic agents in persons with traumatic brain injury. , 1997, Brain injury.
[62] B. Wroblewski,et al. Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. , 1997, Brain injury.
[63] M. Kraus,et al. The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury. , 1997, Brain injury.
[64] W. H. Hall,et al. Rehabilitation of persons with traumatic brain injury. , 1999, NIH consensus statement.
[65] S. Schreiber,et al. Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. , 1998, International clinical psychopharmacology.
[66] D. Berch,et al. Recovery in Pediatric Brain Injury: Is Psychostimulant Medication Beneficial? , 1998, The Journal of head trauma rehabilitation.
[67] J. Duffy,et al. Prevalence of apathy following head injury. , 1998, Brain injury.
[68] Jeffrey A. Brown,et al. Psychopharmacologic Treatment of Acquired Attention Disorders in Children with Brain Injury , 1998, Pediatric Neurosurgery.
[69] Sharon K. McDowell,et al. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. , 1998, Brain : a journal of neurology.
[70] R. Beran,et al. Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine , 1998, Epilepsia.
[71] D. Jeste,et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.
[72] J. Pan,et al. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. , 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica.
[73] J. Calabrese,et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. , 1999, The Journal of clinical psychiatry.
[74] J. Cai,et al. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. , 1999, The Journal of pharmacology and experimental therapeutics.
[75] S. Dursun,et al. Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine. , 1999, Journal of psychiatry & neuroscience : JPN.
[76] Su Qq,et al. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. , 1999 .
[77] J. Whitlock. Brain injury, cognitive impairment, and donepezil. , 1999, The Journal of head trauma rehabilitation.
[78] J. Collier,et al. Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury. , 1999, Brain injury.
[79] D. V. von Cramon,et al. Paroxetine versus citalopram treatment of pathological crying after brain injury. , 1999, Brain injury.
[80] R. Robinson,et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. , 2000, The American journal of psychiatry.
[81] W. Katon,et al. Sertraline in the treatment of major depression following mild traumatic brain injury. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[82] S. Schultz,et al. Donepezil in the Treatment of Cognitive Dysfunction Associated with Traumatic Brain Injury , 2000, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[83] J. Ecklund,et al. Cognitive Rehabilitation for Traumatic Brain Injury , 2000 .
[84] Andrea Laborde,et al. NIH Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury , 2000 .
[85] J. Guralnik,et al. Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.
[86] X. Tang,et al. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat. , 2001, European journal of pharmacology.
[87] M. Bayley,et al. Open-label study of donepezil in traumatic brain injury. , 2001, Archives of physical medicine and rehabilitation.
[88] R. Dempsey,et al. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats , 2001, Brain Research.
[89] P. Sachdev,et al. Schizophrenia-like psychosis following traumatic brain injury: a chart-based descriptive and case–control study , 2001, Psychological Medicine.
[90] S. Marder,et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. , 2001, Archives of general psychiatry.
[91] R. Torta,et al. Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management. , 2001, Brain injury.
[92] K. Taber,et al. Emotional disturbances following traumatic brain injury , 2002, Current treatment options in neurology.
[93] J. Whyte,et al. Psychostimulant Use in the Rehabilitation of Individuals with Traumatic Brain Injury , 2002, The Journal of head trauma rehabilitation.
[94] I. Ahmed,et al. Characteristics of psychotic disorder due to traumatic brain injury: an analysis of case studies in the literature. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[95] M. Rösler. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. , 2002, International journal of clinical practice. Supplement.
[96] Jin Zhou,et al. Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia–ischemia , 2002, Brain Research.
[97] Olli Tenovuo,et al. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. , 2002, The American journal of psychiatry.
[98] W. Burke,et al. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. , 2002, The Journal of clinical psychiatry.
[99] Bruno Vellas,et al. Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer's Disease , 2002, International Psychogeriatrics.
[100] J. Kornhuber,et al. Memantine in moderate-to-severe Alzheimer's disease. , 2003, The New England journal of medicine.
[101] R. van Reekum,et al. A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. , 2003, The Journal of neuropsychiatry and clinical neurosciences.
[102] S. McElroy,et al. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic , 2003, Expert opinion on investigational drugs.
[103] Dm Taylor. ARIPIPRAZOLE: A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE , 2003, International journal of clinical practice.
[104] G. Preston,et al. Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788 , 2004, Psychopharmacology.
[105] M. Markianos,et al. CSF Neurotransmitter metabolites in comatose head injury patients during changes in their clinical state , 2005, Acta Neurochirurgica.